NC
INSM icon

Nexthera Capital’s Insmed INSM Stock Holding History

Nexthera Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-250,000
Closed -$5.05M – 33
2018
Q3 		$5.05M Buy
+250,000
New +$5.65M 0.97% 28

Other funds holding INSM

AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nexthera Capital's INSM Position: Q2 2019 in Review

Nexthera Capital increased its Insmed (INSM) stake by 66% in Q2 2019, buying an estimated $5.19M and bringing the position to 470,741 shares worth $12.1M. The position accounts for 10.04% of the portfolio, ranked #2.

Nexthera Capital first reported a position in INSM in Q1 2016 and has held it in 13 quarters since. The position peaked at $20.7M in Q1 2018. 171 funds tracked by Wall St. Rank hold INSM as of Q2 2019.

  • Nexthera Capital held 470,741 shares of Insmed worth $12.1M as of Q2 2019.
  • Nexthera Capital bought 186,478 Insmed shares in Q2 2019, an estimated $5.19M.
  • Insmed made up 10.04% of Nexthera Capital's portfolio in Q2 2019, its #2 holding.
  • Nexthera Capital first reported a position in Insmed in Q1 2016 and has held it in 13 quarters since.
  • Nexthera Capital's Insmed position peaked at $20.7M in Q1 2018.
  • 171 funds tracked by Wall St. Rank held Insmed as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.